NANOLEK LLC products

HUNTERASE® is indicated for the long-term treatment of patients with Hunter syndrome (mucopolysaccharidosis type II, MPS II)

Anti-tumor necrosis factor-alpha monoclonalantibody. Effective in rheumathoid arthritis, Crohn`s disease, ulcerative colitis, psoriasis, ankylosing spondylitis.

Disease-modifying drug for the treatment of HIV; a second-generation protease inhibitor forming part of standard first-line treatments of HIV.

A vaccine for the prevention of dyphtheria and tetanus, absorbed; for pertussis, acellular; for poliomyelitis, inactivated; for Haemophilus influenzae type b infection, conjugated.

The first inactivated vaccine against poliomyelitis with a full production cycle based in Russia. Used for the immunization of children from the age of 3 months as indicated by the National Immunization Schedule